Merck & Company (6MK) Ratios
Merck & Company Ratios
CH:6MK's free cash flow for Q2 2026 was $4.48B. For the 2026 fiscal year, CH:6MK's free cash flow was decreased by $-893.00M and operating cash flow was $5.37B. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.54 | 1.36 | 1.25 | 1.47 | 1.27 |
| Quick Ratio | 1.30 | 1.15 | 1.00 | 1.23 | 1.02 |
| Cash Ratio | 0.51 | 0.47 | 0.27 | 0.52 | 0.34 |
| Solvency Ratio | 0.29 | 0.31 | 0.06 | 0.29 | 0.24 |
| Operating Cash Flow Ratio | 0.58 | 0.76 | 0.51 | 0.79 | 0.59 |
| Short-Term Operating Cash Flow Coverage | 5.71 | 8.10 | 9.48 | 9.81 | 5.85 |
| Net Current Asset Value | $ -40.69B | $ -31.95B | $ -36.87B | $ -27.38B | $ -37.17B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.37 | 0.33 | 0.34 | 0.29 | 0.33 |
| Debt-to-Equity Ratio | 0.96 | 0.83 | 0.97 | 0.70 | 0.91 |
| Debt-to-Capital Ratio | 0.49 | 0.45 | 0.49 | 0.41 | 0.48 |
| Long-Term Debt-to-Capital Ratio | 0.47 | 0.43 | 0.47 | 0.38 | 0.45 |
| Financial Leverage Ratio | 2.60 | 2.53 | 2.84 | 2.37 | 2.77 |
| Debt Service Coverage Ratio | 6.00 | 5.84 | 2.14 | 6.67 | 5.09 |
| Interest Coverage Ratio | 17.31 | 15.91 | 2.58 | 19.00 | 16.38 |
| Debt to Market Cap | 0.19 | 0.15 | 0.12 | 0.11 | 0.17 |
| Interest Debt Per Share | 20.74 | 15.62 | 14.35 | 13.01 | 14.01 |
| Net Debt to EBITDA | 1.27 | 0.97 | 4.26 | 0.91 | 1.48 |
| Profitability Margins | |||||
| Gross Profit Margin | 71.98% | 76.32% | 73.17% | 70.63% | 72.02% |
| EBIT Margin | 34.54% | 33.05% | 5.05% | 29.36% | 30.15% |
| EBITDA Margin | 43.53% | 40.06% | 11.49% | 35.95% | 36.75% |
| Operating Profit Margin | 36.17% | 31.51% | 4.91% | 30.84% | 27.10% |
| Pretax Profit Margin | 32.45% | 31.07% | 3.14% | 27.74% | 28.50% |
| Net Profit Margin | 28.12% | 26.68% | 0.61% | 24.49% | 26.79% |
| Continuous Operations Profit Margin | 28.13% | 26.70% | 0.63% | 24.50% | 25.37% |
| Net Income Per EBT | 86.65% | 85.86% | 19.32% | 88.29% | 94.02% |
| EBT Per EBIT | 89.70% | 98.59% | 63.95% | 89.95% | 105.15% |
| Return on Assets (ROA) | 13.34% | 14.62% | 0.34% | 13.30% | 12.35% |
| Return on Equity (ROE) | 34.70% | 36.96% | 0.97% | 31.57% | 34.17% |
| Return on Capital Employed (ROCE) | 21.64% | 22.80% | 3.65% | 21.53% | 16.13% |
| Return on Invested Capital (ROIC) | 18.27% | 18.97% | 0.71% | 18.53% | 13.90% |
| Return on Tangible Assets | 20.60% | 21.65% | 0.54% | 21.45% | 21.22% |
| Earnings Yield | 6.93% | 6.80% | 0.13% | 5.17% | 6.73% |
| Efficiency Ratios | |||||
| Receivables Turnover | 5.12 | 6.24 | 5.81 | 6.27 | 5.28 |
| Payables Turnover | 4.13 | 3.72 | 4.11 | 4.08 | 2.96 |
| Inventory Turnover | 2.73 | 2.49 | 2.54 | 2.95 | 2.29 |
| Fixed Asset Turnover | 2.42 | 2.70 | 2.61 | 2.77 | 2.53 |
| Asset Turnover | 0.47 | 0.55 | 0.56 | 0.54 | 0.46 |
| Working Capital Turnover Ratio | 5.08 | 7.62 | 6.70 | 6.63 | 14.26 |
| Cash Conversion Cycle | 116.49 | 107.23 | 117.97 | 92.71 | 105.17 |
| Days of Sales Outstanding | 71.28 | 58.46 | 62.84 | 58.18 | 69.17 |
| Days of Inventory Outstanding | 133.56 | 146.76 | 143.91 | 123.92 | 159.46 |
| Days of Payables Outstanding | 88.35 | 97.99 | 88.77 | 89.39 | 123.46 |
| Operating Cycle | 204.84 | 205.23 | 206.74 | 182.10 | 228.64 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 6.58 | 8.48 | 4.99 | 7.54 | 5.58 |
| Free Cash Flow Per Share | 4.94 | 7.15 | 3.51 | 5.81 | 3.82 |
| Dividend Paid and CapEx Coverage Ratio | 1.34 | 1.91 | 1.15 | 1.68 | 1.28 |
| Capital Expenditure Coverage Ratio | 4.01 | 6.37 | 3.37 | 4.35 | 3.17 |
| Operating Cash Flow Coverage Ratio | 0.33 | 0.56 | 0.36 | 0.60 | 0.41 |
| Operating Cash Flow to Sales Ratio | 0.25 | 0.33 | 0.22 | 0.32 | 0.29 |
| Free Cash Flow Yield | 4.69% | 7.18% | 3.22% | 5.24% | 4.98% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 14.42 | 14.72 | 778.71 | 19.35 | 14.86 |
| Price-to-Sales (P/S) Ratio | 4.06 | 3.93 | 4.73 | 4.74 | 3.98 |
| Price-to-Book (P/B) Ratio | 5.01 | 5.44 | 7.56 | 6.11 | 5.08 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 21.31 | 13.92 | 31.09 | 19.10 | 20.07 |
| Price-to-Operating Cash Flow Ratio | 15.99 | 11.73 | 21.85 | 14.71 | 13.74 |
| Price-to-Earnings Growth (PEG) Ratio | 1.81 | 0.00 | -7.98 | 1.75 | 0.17 |
| Enterprise Value Multiple | 10.59 | 10.77 | 45.41 | 14.08 | 12.32 |
| Enterprise Value | 299.33B | 276.91B | 313.66B | 300.22B | 220.43B |
| EV to EBITDA | 10.59 | 10.77 | 45.41 | 14.08 | 12.32 |
| EV to Sales | 4.61 | 4.32 | 5.22 | 5.06 | 4.53 |
| EV to Free Cash Flow | 24.22 | 15.30 | 34.31 | 20.41 | 22.82 |
| EV to Operating Cash Flow | 18.17 | 12.90 | 24.12 | 15.72 | 15.62 |
| Tangible Book Value Per Share | 1.76 | 3.29 | -0.60 | 1.81 | -2.35 |
| Shareholders’ Equity Per Share | 21.03 | 18.29 | 14.41 | 18.16 | 15.09 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.13 | 0.14 | 0.80 | 0.12 | 0.11 |
| Revenue Per Share | 25.95 | 25.34 | 23.06 | 23.41 | 19.25 |
| Net Income Per Share | 7.30 | 6.76 | 0.14 | 5.73 | 5.16 |
| Tax Burden | 0.87 | 0.86 | 0.19 | 0.88 | 0.94 |
| Interest Burden | 0.94 | 0.94 | 0.62 | 0.94 | 0.95 |
| Research & Development to Revenue | 0.19 | 0.28 | 0.51 | 0.23 | 0.25 |
| SG&A to Revenue | 0.17 | 0.16 | 0.13 | 0.13 | 0.15 |
| Stock-Based Compensation to Revenue | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 |
| Income Quality | 0.90 | 1.25 | 35.63 | 1.31 | 1.14 |
Currency in USD